Central anticholinergic activity of: 2,2-diphenyl-4(3-azabicyclo (3-2-2) non-3-yl) butyramide hydrochloride (SC-13639).
D000818:Animals; D001952:Bridged-Ring Compounds / Q000008:administration & dosage / Q000494:pharmacology*; D002490:Central Nervous System / Q000187:drug effects*; D004336:Drug Antagonism; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009069:Movement Disorders / Q000517:prevention & control; D010276:Parasympatholytics / Q000008:administration & dosage / Q000494:pharmacology*; D011759:Pyrrolidines / Q000037:antagonists & inhibitors; D014203:Tremorine / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D014282:Trihexyphenidyl / Q000494:pharmacology*
D001952:Bridged-Ring Compounds; D010276:Parasympatholytics; D011759:Pyrrolidines; D014282:Trihexyphenidyl; D014203:Tremorine